ClinicalTrials.gg
Not yet recruitingNCT07861789EsCuidar2Updated Oct 26, 2026

A Hybrid Effectiveness-Implementation and Cost-Utility Evaluation of a Support Programme for Informal Carers of People With Dementia in Primary Care (EsCuidar2)

An interventional study of School of Caring Programme in Quality of Life, sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina. Not yet recruiting at 1 site in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-26.

Sponsored by Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Not applicable, Interventional, and Health services research

How we know

Updated Oct 26, 2026Start date movedEligibility revised+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 114 studies in Dementia with a site in Spain — 27 open to participants now, 37 under way, 9 of them phase 3. Dementia · Spain.

Planned enrollment
52nd of 95
200 · median 240
Started
2026
with 8 others
No phase
36 of 114
10 open now
Primary completion
2029-07
later than 31 of 36 live
Registered
113th of 114
by date

Among the 114 studies in Dementia with a site in Spain, this one is the 52nd largest by planned enrollment of the 95 interventional ones that give a count, is one of 9 that started in 2026, is one of 36 with no phase, reaches primary completion later than 31 of the 36 other live ones, and was the 113th registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

27 of the 114 studies in Dementia with a site in Spain are open now. Recruiting first, the newest first:

22 more — sign in →

All 27 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 114 studies in Dementia with a site in Spain, or all of them as a file.
02

Study summary

The aim of this study is to evaluate whether the School of Caring programme improves quality of life and reduces caregiver burden among informal carers of people living with dementia. The study will also examine how the programme is implemented in primary care settings and assess its economic efficiency.

The main questions it aims to answer are:

Does participation in the School of Caring programme improve the quality of life of informal carers of people with dementia? Does the programme reduce the negative impact and burden associated with caregiving? What factors facilitate or hinder the implementation of the programme in primary care centres? Is the programme cost-utility compared with usual care?

Researchers will compare informal carers who participate in the programme with carers who receive usual care.

Participants will:

Take part in nine face-to-face group sessions (one every two weeks) delivered in primary care centres.

Receive health education, information about social and community resources, practical guidance for daily care, physiotherapy and nutritional support, and strategies to promote self-care and emotional well-being.

Share experiences with other carers and participate in peer support activities. Complete study assessments to measure quality of life, caregiver burden and other relevant outcomes throughout the study period.

The study will also collect information on programme implementation and resource use to evaluate the feasibility, sustainability and economic impact of integrating the intervention into routine primary care practice.

03

Conditions studied

  • Quality of Life

Keywords

  • Dementia
  • Caregivers
  • Quality of Life
  • Social Support
  • Self Efficacy
  • Mental Health
  • Health Education
  • Primary Health Care
  • Implementation Science
  • Randomized Controlled Trials
  • Cost-utility
04

Who can participate

The criteria were revised on the registry on Oct 26, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Being an informal caregiver for a person with dementia (ICD-10 codes: G31.84 Cognitive impairment, F03.90 Dementia, F01.5 Vascular dementia, G30 Alzheimer's dementia);
  • Being an informal caregiver for a person with a dependency level of 1 or 2, or a pending dependency assessment, in the Tierras del Ebro region (Catalan Health institute);
  • Being of legal age;
  • Being available to participate in in-person sessions.

Exclusion criteria

Exclusion Criteria:

  • Being an informal caregiver for an institutionalized patient;
  • Having difficulty completing a questionnaire.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Intervention group of the School of Caring Programme

    The programme will be delivered in Primary Care Centre (PCC) training facilities and will consist of two components: 1. Basic programme: Nine face-to-face theoretical and practical sessions will be delivered fortnightly. The programme will include health education, guidance on social and community resources, cognitive behavioural therapy, problem-solving, skills training, physiotherapy support, and nutritional counselling. Group sessions will be facilitated by a multidisciplinary team comprising professionals from family medicine, nursing, physiotherapy, nutrition, social work, and psychology. Prior workshop-based training will be provided to standardise session delivery. 2. Ongoing programme: Following completion of the nine core sessions, each Primary Care Centre (PCC) will be encouraged to continue the programme on a fortnightly basis, indefinitely, as part of routine clinical practice.

    Other: School of Caring Programme

  • No intervention
    Control group

    Participants allocated to this group will receive an individual consultation with a primary care family physician or nurse. Care will be tailored to the caregiver's specific needs and will not follow a standardised protocol. Topics that may be addressed include health education, psychological support, and social care-related concerns.

Interventions

  • OtherSchool of Caring Programme

    School of caring is a program for informal caregivers of people with dementia that stands out from other programs by offering a service close to the community and through the leadership of public primary care in a region of Catalonia characterized by scattered rural areas.

06

What researchers measure

Primary outcomes

  1. Change from Baseline in Health-Related Quality of Life Assessed by the Short Form-36 Health Survey Version 2 (SF-36v2) at 4.5 and 12 Months

    Health-related quality of life (HRQoL) will be assessed using the Short Form-36 Health Survey Version 2 (SF-36v2 Health Survey; QualityMetric/Optum), a validated self-administered questionnaire comprising 36 items covering eight health domains: physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health. The SF-36v2 will be scored using the QualityMetric norm-based scoring algorithm, generating scores for the eight health domains and the Physical Component Summary (PCS) and Mental Component Summary (MCS). Norm-based scores are standardized against the reference population, with a mean of 50 and a standard deviation of 10; higher scores indicate better health-related quality of life. The SF-36v2 will be completed by all participants.

    Time frame: Baseline, 4.5 months (end of the basic programme), and 12 months

Secondary outcomes

  1. Change from Baseline in Caregiver Burden Assessed by the Zarit Burden Interview (ZBI) at 4.5 and 12 Months

    Caregiver burden will be measured using the Zarit Burden Interview (ZBI), a validated self-administered instrument assessing the perceived impact of caregiving on emotional, physical, social, and financial well-being. The commonly used 22-item version yields a total score ranging from 0 to 88. Higher scores indicate greater caregiver burden, with increasing scores reflecting increasing levels of perceived burden.

    Time frame: Baseline, 4.5 months (end of the basic programme), and 12 months.

  2. Change from Baseline in Self-Efficacy Assessed by the General Self-Efficacy Scale (GSES) at 4.5 and 12 Months

    Self-efficacy will be measured using the General Self-Efficacy Scale (GSES), a validated 10-item questionnaire designed to assess an individual's perceived ability to cope with challenging situations and manage difficulties effectively. Total scores range from 10 to 40, with higher scores indicating greater perceived self-efficacy.

    Time frame: Baseline, 4.5 months (end of the basic programme), and 12 months.

  3. Change from Baseline in Mental Well-Being Assessed by the Warwick-Edinburgh Mental Well-being Scale (WEMWBS) at 4.5 and 12 Months

    Mental well-being will be assessed using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS), a validated 14-item instrument covering positive affect, psychological functioning, and interpersonal relationships. Total scores range from 14 to 70, with higher scores indicating greater positive mental well-being.

    Time frame: Baseline, 4.5 months (end of the basic programme), and 12 months.

  4. Change from Baseline in Perceived Social Support Assessed by the Oslo Social Support Scale (OSSS-3) at 4.5 and 12 Months

    Social support will be measured using the Oslo Social Support Scale (OSSS-3), a brief validated instrument consisting of three items assessing the availability of close relationships, concern and interest from others, and access to practical support. Total scores range from 3 to 14, with higher scores indicating stronger perceived social support. Scores of 3-8 indicate poor social support, 9-11 moderate social support, and 12-14 strong social support.

    Time frame: Baseline, 4.5 months (end of the basic programme), and 12 months.

07

Study locations

1 site
  • Unitat de Suport a la Recerca Terres de l'Ebre
    Tortosa, Tarragona 43500, Spain
    • Alessandra Q Gonçalves, PhD · Contactaqueiroga.ebre.ics@gencat.cat · +34 977 58 89 11
    • Claudia C Romeu, PhD · Principal investigator
    • Alessandra Q Gonçalves, PhD · Sub investigator
    • Ester G Espelta, PhD · Sub investigator
    • José F Sáez, PhD · Sub investigator
    • Nuria Brunet · Sub investigator
    • Laura Bel · Sub investigator
    • Georgina Cardona · Sub investigator
    • Evelin Mascarell · Sub investigator
    • Rosa D Llorca, PhD · Sub investigator
    • Itziar Atxutegi · Sub investigator
    • Misericordia Carles · Sub investigator
    • Maria José Pérez · Sub investigator
08

References and documents

Individual participant data

Plan to share: No — As the project collects sensitive health data from participants, individual data will not be shared. Aggregated data that do not allow for the identification of individuals will be shared upon request to the principal investigator.

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Jul 2029, 32 months later.

Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 32 months is above that.

Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.

Start moved once since we started tracking on Sep 25, 2026: Oct 2026 → Nov 2026, on Oct 26, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2026
First posted
Oct 6, 2026
StartEst.
Nov 2026was Oct 2026
Primary completionEst.
Jul 2029
CompletionEst.
Dec 2029
Last update
Oct 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Oct 2026→Nov 2026
Oct 26, 2026
Eligibility
1 inclusion criterion edited, 3 added; 1 exclusion criterion edited, 1 added
What changed in the criteria
Inclusion criteria
  • EditedBeing an informal caregiver for a person with (a) dementia (ICD-10 codes: G31.84 Cognitive impairment, F03.90 Dementia, F01.5 Vascular dementia, G30 Alzheimer's dementia); (b) with a dependency level of 1 or 2, or a pending dependency assessment, in the Tierras del Ebro region (Catalan Health institute); (c) being of legal age; and (d) availability to participate in in-person sessions.
  • AddedBeing an informal caregiver for a person with a dependency level of 1 or 2, or a pending dependency assessment, in the Tierras del Ebro region (Catalan Health institute);
  • AddedBeing of legal age;
  • AddedBeing available to participate in in-person sessions.
Exclusion criteria
  • Editeda) beingBeing an informal caregiver for an institutionalized patient, or (b) having difficulty completing a questionnaire.;
  • AddedHaving difficulty completing a questionnaire.
Oct 26, 2026
Registered
First appeared on the registry
Oct 6, 2026
Show all 2 updates
  1. Oct 26, 2026
    Start date Oct 2026→Nov 2026
    Eligibility 1 inclusion criterion edited, 3 added; 1 exclusion criterion edited, 1 added
    What changed in the criteria
    Inclusion criteria
    • EditedBeing an informal caregiver for a person with (a) dementia (ICD-10 codes: G31.84 Cognitive impairment, F03.90 Dementia, F01.5 Vascular dementia, G30 Alzheimer's dementia); (b) with a dependency level of 1 or 2, or a pending dependency assessment, in the Tierras del Ebro region (Catalan Health institute); (c) being of legal age; and (d) availability to participate in in-person sessions.
    • AddedBeing an informal caregiver for a person with a dependency level of 1 or 2, or a pending dependency assessment, in the Tierras del Ebro region (Catalan Health institute);
    • AddedBeing of legal age;
    • AddedBeing available to participate in in-person sessions.
    Exclusion criteria
    • Editeda) beingBeing an informal caregiver for an institutionalized patient, or (b) having difficulty completing a questionnaire.;
    • AddedHaving difficulty completing a questionnaire.
    + 3 other changes: identifiers, verification date and conditions
  2. Oct 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07861789
Collaborators
Institut Català de la Salut, Servicio Gallego de Salud, Biobizkaia Health Research Institute, University Rovira i Virgili
Responsible party
Sponsor
First posted
Oct 6, 2026
Start date
Nov 2026 (estimated)
Primary completion
Jul 2029 (estimated)
Completion
Dec 2029 (estimated)
Last update
Oct 26, 2026

Study contacts

Alessandra Q Gonçalves, PhD
Contact
aqueiroga.ebre.ics@gencat.cat
+34 977 58 89 11 ext. 1122
Claudia C. Romeu, PhD
principal investigator · Catalan Institute of Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion